Neutralizing Antibody Market Growth Accelerated by Rising Demand For Treatment Of Cancer And Viral Infections

Neutralizing Antibody Market


Neutralizing antibodies are antibodies that are directed against specific antigens or pathogen epitopes and can neutralize pathogenic effects of macromolecules like proteins on cells or in extracellular space. Neutralizing antibodies help treat diseases like cancer, HIV, and infectious diseases by blocking the activity of targeted pathogens or antigens.

The global Neutralizing Antibody Market is estimated to be valued at US$ 1.87 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The growing prevalence of cancer and viral infections is the major factor augmenting the growth of the Neutralizing Antibody Market. As per WHO, cancer accounted for nearly 10 million deaths in 2020. Strong R&D efforts by key players to develop monoclonal neutralizing antibodies for treatment of various types of cancer is creating high demand for neutralizing antibodies. Additionally, neutralizing antibodies that target epitopes on the surface of viruses help block viral entry and neutralize viral infectivity, thereby driving their use for treatment of viral diseases like HIV, influenza, Ebola etc. Mohawk and other key players are heavily investing in research to expand therapeutic applications of neutralizing antibodies. This is further expected to boost the neutralizing antibody market growth over the forecast period.

Segment Analysis

The global neutralizing antibody market is dominated by the monoclonal antibodies segment. This segment accounted for the highest revenue share in 2024 due to the increasing demand for monoclonal antibodies in various therapeutic applications for treating chronic diseases such as cancer and autoimmune disorders. Monoclonal antibodies are preferred over polyclonal antibodies due to advantages such as high specificity and reproducibility.

Key Takeaways

The global neutralizing antibody market is expected to witness high growth. Global Neutralizing Antibody Market Size is estimated to be valued at US$ 1.87 Billion in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031.

Regional analysis related content comprises the North America region is expected to dominate the global neutralizing antibody market during the forecast period. This is attributed to well-established healthcare infrastructure, rising prevalence of chronic diseases, growing geriatric population, and increasing R&D investments by key players in the region.

Key players operating in the neutralizing antibody market are Mohawk, Regeneron Pharmaceuticals, Vir Biotechnology, AstraZeneca, Eli Lilly, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, AbbVie, Novartis, Johnson & Johnson, and Bayer.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides